Skip to main content
Clinical Trials/NCT04906681
NCT04906681
Unknown
Phase 1

Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study

PXL University College0 sites40 target enrollmentSeptember 1, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Arthroplasty
Sponsor
PXL University College
Enrollment
40
Primary Endpoint
Canadian Occupational Performance Measure
Last Updated
4 years ago

Overview

Brief Summary

Rehabilitation technology is more and more implemented in conventional therapy to increase the dosage of therapy and/or increase patient's motivation towards therapy. In orthopedic as well as neurological rehabilitation it is important to exercise with enough intensity and repetitions to improve functional performance in activities of daily life, and consequently quality of life. At the moment, not all (rehabilitation) technologies are adapted towards the wishes and needs of both patients and therapists for everyday use in the clinical setting. Also, not all technologies are fit for independent use by the patients. Researcher of PXL have developed a Kinect-based system (i.e. i-ACT) for rehabilitation and performed supervised research with i-ACT in neurological and musculoskeletal rehabilitation, and older adults. Within this research, patients will exercise with i-ACT under supervision of their therapist during weekdays, but in the weekends they will be motivated by the medical staff to perform their exercises with i-ACT. The medical staff will be present for safety reasons, but the patient is asked to use and exercise with i-ACT as independent as possible. The aim of this research is to explore to which extend i-ACT is suitable for semi-independent use by patients in orthopedic or neurological rehabilitation.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
July 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
PXL University College
Responsible Party
Principal Investigator
Principal Investigator

Els Knippenberg

Principal investigator

PXL University College

Eligibility Criteria

Inclusion Criteria

  • age over 18 years old
  • post-operation of arthroplasty (hip or knee), or official medical diagnosis of stroke or Parkinson's disease
  • understand Dutch instructions
  • patient at St-Trudo ziekenhuis
  • experiencing problems in functional performance

Exclusion Criteria

  • spasticity (Brunström Fugl-Meyer \< 50)
  • cognitive disfunction (Mini Mental State Examination \< 24)
  • visual impairment (blind, cataract, etc.)
  • persons who are not able to exit electric wheelchair

Outcomes

Primary Outcomes

Canadian Occupational Performance Measure

Time Frame: 4 weeks

The Canadian Occupational Performance Measure (COPM) is an evidence-based outcome measure designed to capture a client's self-perception of performance in everyday living, over time. Scores range from 0 to 10 (best score) in each defined goal.

Secondary Outcomes

  • 2 Minute Walking Test(4 weeks)
  • Intrinsic Motivation Inventory(4 weeks)
  • Wolf Motor Function Test(4 weeks)
  • Barthel Index(4 weeks)
  • System Usability Scale(4 weeks)
  • Timed Up and Go test(4 weeks)

Similar Trials